Skip to main content

Advertisement

Log in

Daptomycin nonsusceptible enterococci in hematologic malignancy and hematopoietic stem cell transplant patients: an emerging threat

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Matar MJ, Tarrand J, Raad I, Rolston KV (2006) Colonization and infection with vancomycin-resistant Enterococcus among patients with cancer. Am J Infect Control 34(8):534–536

    Article  PubMed  Google Scholar 

  2. Weinstock DM, Conlon M, Iovino C, Aubrey T, Gudiol C, Riedel E et al (2007) Colonization, bloodstream infection, and mortality caused by vancomycin-resistant enterococcus early after allogeneic hematopoietic stem cell transplant. Biol Blood Marrow Transplant 13(5):615–621

    Article  PubMed  Google Scholar 

  3. Linden PK (2007) Optimizing therapy for vancomycin-resistant enterococci (VRE). Semin Respir Crit Care Med 28(6):632–645

    Article  PubMed  Google Scholar 

  4. Kelesidis T, Humphries R, Uslan DZ, Pegues DA (2011) Daptomycin nonsusceptible enterococci: an emerging challenge for clinicians. Clin Infect Dis 52(2):228–234

    Article  PubMed  Google Scholar 

  5. Sader HS, Jones RN (2009) Antimicrobial susceptibility of Gram-positive bacteria isolated from US medical centers: results of the Daptomycin Surveillance Program (2007–2008). Diagn Microbiol Infect Dis 65(2):158–162

    Article  PubMed  CAS  Google Scholar 

  6. Kamboj M, Cohen N, Gilhuley K, Babady NE, Seo SK, Sepkowitz KA (2011) Emergence of daptomycin-resistant VRE: experience of a single institution. Infect Control Hosp Epidemiol 32(4):391–394

    Article  PubMed  Google Scholar 

  7. Silverman JA, Oliver N, Andrew T, Li T (2001) Resistance studies with daptomycin. Antimicrob Agents Chemother 45(6):1799–1802

    Article  PubMed  CAS  Google Scholar 

  8. Palmer KL, Daniel A, Hardy C, Silverman J, Gilmore MS (2011) Genetic basis for daptomycin resistance in enterococci. Antimicrob Agents Chemother 55(7):3345–3356

    Article  PubMed  CAS  Google Scholar 

  9. Kelesidis T, Humphries R, Uslan DZ, Pegues D (2012) De novo daptomycin-nonsusceptible enterococcal infections. Emerg Infect Dis 18(4):674–676

    Article  PubMed  Google Scholar 

  10. King ST, Usery JB, Holloway K, Koeth L, Cleveland KO, Gelfand MS (2011) Successful therapy of treatment-emergent, non-clonal daptomycin-non-susceptible Enterococcus faecium infections. J Antimicrob Chemother 66(11):2673–2675

    Article  PubMed  CAS  Google Scholar 

Download references

Financial disclosure statement

The authors have nothing to disclose.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kitsada Wudhikarn.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wudhikarn, K., Gingrich, R.D. & de Magalhaes Silverman, M. Daptomycin nonsusceptible enterococci in hematologic malignancy and hematopoietic stem cell transplant patients: an emerging threat. Ann Hematol 92, 129–131 (2013). https://doi.org/10.1007/s00277-012-1539-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-012-1539-6

Keywords

Navigation